company logo
immunitoAI is a biotech startup that leverages AI to revolutionise antibody discovery and therapeutics.
Basic Information
immunitoAI’s full-stack platform predicts the best therapeutic antibody candidates, saving time by 60 percent and money by 50 percent, and doubling the efficiency. Their first product named imRANK is an AI which screens and ranks existing antibody sequences to predict the best binding strength with a given antigen of one’s choice. imRANK is in the R&D phase, the beta version will be available soon. Their second product named imEVOLVE is an AI which identifies and mutates regions of antibodies that aids in higher binding affinity with the antigen of one’s choice.
Legal Name
:
immunitoAI Private Limited
Headquarters
:
Bangalore, Karnataka, India
Business Model
:
B2B  
Founding Date
:
2020
No. of Employees
:
<10
Core Team
:
1.  
Aridni Shah
Co-Founder & CEO
2.  
Trisha Chatterjee
Co-Founder & CTO
Funding

Total Funding

$1.0M

Investors
:
1.  
Pi Ventures
2.  
Entrepreneur First
Detail Round Breakdown
Round 1

$55k

Series Name
:
PRE-SEED
Date
:
5th Mar 2021
Recently Added Startups
Recently Added Startups